Lyra Therapeutics, Inc. (OTC:LYRA) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Joseph Edelman Other companies: Kardigan, Inc. (Director · Since at least Jun 17, 2026); Immatics N.V. (Director · Since at least Mar 18, 2026); Solid Biosciences Inc. (Director · Since at least Mar 23, 2021); MeiraGTx Holdings plc (Director · Since at least Nov 23, 2020); LeonaBio, Inc. (Director · Since at least Sep 17, 2020); Adagio Medical Holdings, Inc (Director · Jan 22, 2025 – Jan 22, 2025 · Past); Freenome, Inc. (Director · Jun 11, 2024 – Jun 11, 2024 · Past); ARYA Sciences Acquisition Corp V (Director · Jul 12, 2021 – Jul 12, 2021 · Past); ARYA Sciences Acquisition IV Corp (Director · Feb 25, 2021 – Jul 31, 2024 · Past); Landos Biopharma Inc (Director · Feb 3, 2021 – Aug 27, 2021 · Past); Astria Therapeutics Inc (Director · Jan 28, 2021 – Feb 1, 2024 · Past); Nautilus Biotechnology, Inc. (Director · Aug 6, 2020 – Jun 14, 2024 · Past); Cerevel Therapeutics Holdings Inc (Director · Jun 4, 2020 – Feb 20, 2024 · Past); ARYA Sciences Acquisition Corp (Director · Oct 5, 2018 – Oct 5, 2018 · Past) | Director · Apr 30, 2020 – May 31, 2023 · Past |
| Robert Langer Other companies: Seer, Inc. (Director · Since at least Dec 3, 2020); Korro Bio, Inc. (Director · Oct 2, 2019 – Aug 17, 2022 · Past); Moderna, Inc. (Director · Dec 7, 2018 – May 6, 2024 · Past); Rubius Therapeutics Inc (Director · Jul 17, 2018 – Oct 14, 2019 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 12, 2018 · Past); BIND Therapeutics Inc (Director · Sep 19, 2013 – Jun 21, 2016 · Past); Ocata Therapeutics Inc (Director · Oct 4, 2011 – Feb 10, 2016 · Past) | David H. Koch Institute Professor, Massachusetts Institute of Technology · Since at least Apr 30, 2020 |
| John Bishop Other companies: Ardelyx, Inc. (Chief Technical and Quality Officer · Since at least Aug 1, 2025); Forma Therapeutics Holdings Inc (SVP, Chief Technology Officer · Jun 14, 2021 – Oct 14, 2022 · Past); Veracyte, Inc. (Director · Dec 1, 2014 – Jul 17, 2023 · Past); Cepheid (Chairman of the Board and CEO, Director · Feb 26, 2009 – Nov 4, 2016 · Past); Conceptus Inc (Director · Feb 25, 2009 – Jun 5, 2013 · Past); Momenta Pharmaceuticals Inc (Senior VP, Pharmaceutical Scie · Feb 17, 2006 – May 19, 2016 · Past) | Chief Technology Officer · Feb 27, 2023 – Jan 30, 2024 · Past |
| Konstantin Poukalov Other companies: ARYA Sciences Acquisition Corp V (Chief Business Officer · Jul 12, 2021 – Jul 12, 2021 · Past); ARYA Sciences Acquisition IV Corp (Chief Business Officer · Feb 25, 2021 – Jul 31, 2024 · Past); Landos Biopharma Inc (Director · Feb 3, 2021 – Feb 8, 2021 · Past); Nautilus Biotechnology, Inc. (Chief Business Officer · Aug 6, 2020 – Aug 6, 2020 · Past); Cerevel Therapeutics Holdings Inc (Chief Business Officer · Jun 4, 2020 – Jun 4, 2020 · Past); Kadmon Holdings Inc (Executive Vice President, CFO · Jul 26, 2016 – Dec 8, 2017 · Past) | Director · Apr 30, 2020 – Jun 13, 2024 · Past |
| Don Elsey Other companies: BullFrog AI Holdings, Inc. (Director · Since at least Feb 13, 2023); RegeneRx Biopharmaceuticals, Inc. (Member of our Board of Directors · Since at least Sep 1, 2017); CapForce Inc. (Director · Feb 21, 2019 – Jun 7, 2023 · Past); Senseonics Holdings, Inc. (CFO, Secretary and Treasurer · Apr 12, 2016 – Feb 2, 2018 · Past) | CFO, Treasurer & Secretary · Apr 30, 2020 – Feb 8, 2021 · Past |
| Bradford Smith Other companies: Q32 Bio Inc. (See remarks · Mar 27, 2018 – Feb 23, 2023 · Past); Ocular Therapeutix, Inc. (CFO and Treasurer · Jul 24, 2014 – Jan 31, 2017 · Past); NeuroMetrix Inc (Chief Financial Officer · Jan 4, 2006 – Apr 1, 2008 · Past) | Board Director · Since at least Apr 30, 2020 |
| C Ann Merrifield Other companies: Juniper Pharmaceuticals Inc (Director · Jul 16, 2015 – Aug 14, 2018 · Past); InVivo Therapeutics Holdings Corp (Director · Nov 8, 2014 – Nov 17, 2022 · Past); Flexion Therapeutics Inc (Director · Jun 11, 2014 – Nov 19, 2021 · Past) | Director · Apr 30, 2020 – May 14, 2025 · Past |
| Edward T Anderson Other companies: Couchbase Inc (Director · Since at least Jul 21, 2021); One (AONE) (Director · Jul 14, 2021 – Apr 25, 2025 · Past); Sonus Networks Inc (Director · Dec 17, 2007 – Dec 17, 2007 · Past) | Director · Apr 30, 2020 – Jun 30, 2023 · Past |
| George Whitesides Other companies: Theravance Biopharma, Inc. (Director · May 14, 2014 – Apr 27, 2021 · Past); Innoviva, Inc. (Director · Apr 26, 2006 – May 22, 2014 · Past); Rohm & Haas Co (Director · Jan 9, 2006 – Apr 1, 2009 · Past) | Woodford L. and Ann A. Flowers University Professor, Harvard University · Since at least Apr 30, 2020 |
| James R. Tobin Other companies: TransMedics Group, Inc. (Director · Since at least Feb 9, 2021); Globus Medical, Inc. (Director · Since at least Jan 14, 2021); Oxford Immunotec Global PLC (Director · Mar 8, 2021 – Mar 8, 2021 · Past) | Lead Independent Director · Since at least Mar 4, 2022 |
| Michael Seth Altman Other companies: ARYA Sciences Acquisition IV Corp (Chief Financial Officer, Director · Jul 31, 2024 – Jul 31, 2024 · Past); Freenome, Inc. (Chief Business Officer, Director · Jun 11, 2024 – Jun 13, 2024 · Past); Nautilus Biotechnology, Inc. (Director · Jun 15, 2022 – Jun 14, 2024 · Past) | Director · Jun 16, 2022 – Jun 13, 2024 · Past |
| Nancy L. Snyderman Other companies: Alkermes plc (Director · Since at least May 23, 2018); Future Health Esg Corp (Director · Sep 9, 2021 – Oct 24, 2021 · Past); Axonics Modulation Technologies Inc (Director · Apr 8, 2019 – Aug 24, 2020 · Past) | Board Director · Since at least Oct 27, 2020 |
| Harlan Waksal Other companies: Freenome, Inc. (Director · Jun 11, 2024 – Jun 11, 2024 · Past); Kadmon Holdings Inc (President, CEO, Director · Jul 26, 2016 – Nov 9, 2021 · Past) | Executive Chair, Director · Feb 16, 2022 – Dec 9, 2024 · Past |
| Maria Palasis Other companies: Beta Bionics, Inc. (Board Member · Since at least Jan 29, 2025) | President and Chief Executive Officer · Since at least Apr 30, 2020 |
| Corinne Noyes | See Remarks · Apr 30, 2020 – Jan 31, 2023 · Past |
| Jason Cavalier | Principal Financial Officer · Since at least Sep 13, 2021 |
| Pamela E Nelson | SVP, Regulatory Affairs · Aug 3, 2020 – Feb 12, 2022 · Past |
| Richard Nieman | Chief Medical Officer · Jul 11, 2022 – Jan 30, 2024 · Past |
| Robert E Richard | SVP, Technical Operations · Jun 24, 2020 – Jan 31, 2023 · Past |